Cognition Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Cognition Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cognition Therapeutics Inc
Rating: 1.52600
Author: Trendlyne DVM scores

about

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its ...

0.57 -0.13 (-18.57%)

77.56% Fall from 52W High

9.1M

XNAS Volume

High vol.+gain this week

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.0 / 100

Technically Neutral

54.0 / 100

No estimates available

Cognition Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cognition Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its ...

77.56% Fall from 52W High

High vol.+gain this week

SWOT Analysis

Cognition Therapeutics Inc Live Price Chart